Interleukin 6 as a Predictive Biomarker for Atrial Fibrillation after Coronary Bypass Grafting: A Systematic Review
PDF

Keywords

Atrial Fibrillation
Interleukin-6
Coronary Artery Bypass
Biomarkers
Inflammatory Process
Systematic Review

Categories

How to Cite

1.
Gomes da Mata R, Adorno de Lima AL, da Silva Menezes Junior A. Interleukin 6 as a Predictive Biomarker for Atrial Fibrillation after Coronary Bypass Grafting: A Systematic Review. Integr J Med Sci [Internet]. 2021 Mar. 8 [cited 2021 Oct. 26];8. Available from: https://mbmj.org/index.php/ijms/article/view/454

Abstract

Atrial fibrillation (AF) progresses after coronary bypass grafting in 11–40% of patients. Plasma biomarkers such as interleukin 6 (IL-6) can assess the risk of AF development. We performed a systematic review using as sources:  PubMed, LILACS, and Cochrane Library databases were investigated using Boolean operators and MeSH terms (Medical Subject Headings Terms) “Atrial Fibrillation AND Interleukin AND Biomarkers”.  As the following eligibility criteria: observational studies, studies with coronary artery bypass grafting with plasma levels of IL-6 recorded after screening, 11 articles were selected. Three studies met the inclusion and exclusion criteria. Results: IL-6 levels on AF group - Ishida et al. reported the plasma levels of IL-6 during the post-operative period as 360 ± 143 pg/mL, while Pretorius et al. reported it to be 380.6 ± 151.1 pg/mL. Lastly, Ziabakhsh-Tabari et al. reported a post-operative plasma IL-6 level of 38.2 ± 32 pg/mL. It is considered that new studies about the object are necessary, and these studies should be more standardized. Preferably, it would be important for the daily measurement of IL-6 and its correlation with AF development for statistical analysis to set the best time for sample collection and cut-off value.

https://doi.org/10.15342/ijms.2021.454
PDF

Metrics

Metrics Loading ...